586 related articles for article (PubMed ID: 2949010)
21. Potentiation of tumor lysis by a bispecific antibody that binds to CA19-9 antigen and the Fc gamma receptor expressed by human large granular lymphocytes.
de Palazzo IG; Gercel-Taylor C; Kitson J; Weiner LM
Cancer Res; 1990 Nov; 50(22):7123-8. PubMed ID: 2146012
[TBL] [Abstract][Full Text] [Related]
22. Biologic effects of gamma interferon pre-treatment followed by monoclonal antibody 17-1A administration in patients with gastrointestinal carcinoma.
Weiner LM; Steplewski Z; Koprowski H; Sears HF; Litwin S; Comis RL
Hybridoma; 1986 Jul; 5 Suppl 1():S65-77. PubMed ID: 3091476
[TBL] [Abstract][Full Text] [Related]
23. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
24. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
Frey JR; Kamber M; Peck R
Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
[TBL] [Abstract][Full Text] [Related]
25. Interferon-gamma restores T lymphocyte proliferation of nonresponders to IgG1 anti-CD3 via the induction of Fc gamma 1 receptors on monocytes.
Benichou G; Kanellopoulos JM; Wallon C; Boue F; Delfraissy JF
Eur J Immunol; 1987 Aug; 17(8):1175-81. PubMed ID: 2957217
[TBL] [Abstract][Full Text] [Related]
26. Characterization and structural analysis of Fc gamma receptors of human monocytes, a monoblast cell line (U937) and a myeloblast cell line (HL-60) by a monoclonal antibody.
Frey J; Engelhardt W
Eur J Immunol; 1987 May; 17(5):583-91. PubMed ID: 2953612
[TBL] [Abstract][Full Text] [Related]
27. IFN-alpha and IFN-gamma can affect both monocytes and tumor cells to modulate monocyte-mediated cytotoxicity.
Webb DS; Gerrard TL
J Immunol; 1990 May; 144(9):3643-8. PubMed ID: 2158515
[TBL] [Abstract][Full Text] [Related]
28. Bispecific antibody-dependent cellular cytotoxicity of HER2/neu-overexpressing tumor cells by Fc gamma receptor type I-expressing effector cells.
Keler T; Graziano RF; Mandal A; Wallace PK; Fisher J; Guyre PM; Fanger MW; Deo YM
Cancer Res; 1997 Sep; 57(18):4008-14. PubMed ID: 9307286
[TBL] [Abstract][Full Text] [Related]
29. Initial trial of bispecific antibody-mediated immunotherapy of CD15-bearing tumors: cytotoxicity of human tumor cells using a bispecific antibody comprised of anti-CD15 (MoAb PM81) and anti-CD64/Fc gamma RI (MoAb 32).
Ball ED; Guyre PM; Mills L; Fisher J; Dinces NB; Fanger MW
J Hematother; 1992; 1(1):85-94. PubMed ID: 1365020
[TBL] [Abstract][Full Text] [Related]
30. Structural requirements of immunoglobulin G for binding to the Fc gamma receptors of the human tumor cell lines U937, HL-60, ML-1, and K562.
McCool D; Birshtein BK; Painter RH
J Immunol; 1985 Sep; 135(3):1975-80. PubMed ID: 3860563
[TBL] [Abstract][Full Text] [Related]
31. Proteolysis induces increased binding affinity of the monocyte type II FcR for human IgG.
van de Winkel JG; van Ommen R; Huizinga TW; de Raad MA; Tuijnman WB; Groenen PJ; Capel PJ; Koene RA; Tax WJ
J Immunol; 1989 Jul; 143(2):571-8. PubMed ID: 2525588
[TBL] [Abstract][Full Text] [Related]
32. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
Wu L; Adams M; Carter T; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB
Clin Cancer Res; 2008 Jul; 14(14):4650-7. PubMed ID: 18628480
[TBL] [Abstract][Full Text] [Related]
33. Distinct functions of surface receptors in the induction of neutrophil-mediated cytotoxicity.
Cordier G; Samarut C; Revillard JP
Ann Immunol (Paris); 1981; 132D(1):3-14. PubMed ID: 7347555
[TBL] [Abstract][Full Text] [Related]
34. Blockade of Fc receptor-mediated binding to U-937 cells by murine monoclonal antibodies directed against a variety of surface antigens.
Kurlander RJ
J Immunol; 1983 Jul; 131(1):140-7. PubMed ID: 6223069
[TBL] [Abstract][Full Text] [Related]
35. Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.
Le J; Prensky W; Yip YK; Chang Z; Hoffman T; Stevenson HC; Balazs I; Sadlik JR; Vilcek J
J Immunol; 1983 Dec; 131(6):2821-6. PubMed ID: 6417232
[TBL] [Abstract][Full Text] [Related]
36. Construction and characterization of a humanized anti-gamma-Ig receptor type I (Fc gamma RI) monoclonal antibody.
Graziano RF; Tempest PR; White P; Keler T; Deo Y; Ghebremariam H; Coleman K; Pfefferkorn LC; Fanger MW; Guyre PM
J Immunol; 1995 Nov; 155(10):4996-5002. PubMed ID: 7594506
[TBL] [Abstract][Full Text] [Related]
37. Involvement of tumor necrosis factor in cytotoxicity mediated by human monocytes.
Nissen-Meyer J; Hofsli E; Espevik T; Austgulen R
Nat Immun Cell Growth Regul; 1988; 7(5-6):266-79. PubMed ID: 3146697
[TBL] [Abstract][Full Text] [Related]
38. Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing.
Coney LR; Mezzanzanica D; Sanborn D; Casalini P; Colnaghi MI; Zurawski VR
Cancer Res; 1994 May; 54(9):2448-55. PubMed ID: 7512887
[TBL] [Abstract][Full Text] [Related]
39. Mapping the functional topography of Fc gamma with monoclonal antibodies: localization of epitopes interacting with the binding sites of Fc receptor on human K cells.
Sármay G; Jefferis R; Klein E; Benczur M; Gergely J
Eur J Immunol; 1985 Oct; 15(10):1037-42. PubMed ID: 2414110
[TBL] [Abstract][Full Text] [Related]
40. Human monocytes and U937 cells bear two distinct Fc receptors for IgG.
Looney RJ; Abraham GN; Anderson CL
J Immunol; 1986 Mar; 136(5):1641-7. PubMed ID: 2936805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
